Call Start: 08:00 January 1, 0000 8:39 AM ET

Esperion Therapeutics, Inc. (NASDAQ:ESPR)

Q3 2022 Earnings Conference Call

November 1, 2022 08:00 ET

Company Participants

Tiffany Aldrich - Associate Director, Corporate Communications

Sheldon Koenig - President & Chief Executive Officer

JoAnne Foody - Chief Medical Officer

Eric Warren - Chief Commercial Officer

Benjamin Halladay - Senior Director of Finance

Conference Call Participants

Mike Yee - Jefferies

Serge Belanger - Needham & Company

Tom Shrader - BTIG

Mike Riad - Morgan Stanley

Joseph Thome - Cowen

Jason Butler - JMP Securities

Judah Frommer - Credit Suisse

Paul Choi - Goldman Sachs

Tiffany Aldrich

Good morning and welcome to Esperion's Third Quarter 2022 Financial Results and Company Update Conference Call. I'm Tiffany Aldrich and I'm part of the Corporate Communications team here at Esperion.

I want to remind callers that the information discussed on the call today is covered under the safe harbor provision of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in today's press release and our SEC filings. The content of this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, November 1, 2022. We undertake no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call and webcast. As a reminder, this conference call and webcast are being recorded and archived. We issued a press release this morning detailing the content of today's call. A copy can be found at www.esperion.com within the Investors and Media section. We will begin with prepared comments and then open the call for your questions. Following today’s call, the team will be available for follow-up questions. Please e-mail corporate team at sperion.com to schedule a time to speak with the team.

With us today are Sheldon Koenig, President and I; Dr. JoAnne Foody, Chief Medical Officer; Eric Warren, Chief Commercial Officer; BJ Swartz, Chief Strategy Officer; and Ben Halladay from our Finance department.

I’ll now turn the call over to Sheldon for some prepared remarks. Sheldon?

Sheldon Koenig

Thank you, Tiffany and good morning, everyone. Thank you for joining us today to review our recent progress in the third quarter of 2022 and reaffirm our goals for the remainder of the year. This is an exciting time for Esperion as we focus on CLEAR Outcomes. The entire organization is working diligently on executing quality site closeout and ensuring accurate data collection.